Investors displayed caution this week, resulting in a few significant funding rounds. Safe Superintelligence, an artificial intelligence company, raised $1 billion, increasing its valuation to $5 billion. This funding, supported by investors like Andreessen Horowitz and Sequoia Capital, aims to enhance computing capabilities and expand the workforce. Arsenal Biosciences secured $325 million for T-cell therapies, targeting various cancers, raising a total of $631 million since 2019. eGenesis achieved $191 million in Series D funding to advance human-compatible engineered organs and follow a successful pig kidney transplant. Circle Pharma obtained $90 million for cell-permeable macrocycles, raising nearly $208 million since its 2012 founding. 24M Technologies secured $87 million for energy storage solutions, maintaining a $1.3 billion valuation. OrsoBio raised $67 million for obesity-related treatments, while Cortex Applications secured $60 million to improve developer tools. Oyster received $59 million to enhance HR services, and Laravel raised $57 million in its first funding round in Arkansas City. Sonoma BioTherapeutics received a $45 million milestone payment from Regeneron Pharmaceuticals. Internationally, Sakana AI from Japan raised $100 million for generative AI models. The week's funding rounds highlight ongoing investment interest in AI and biotech across various industries.

Learn more on this news visit us at:

https://theweb3.news/news-bites/discover-the-secrets-behind-this-weeks-largest-startup-funding-deals/

Hosted on Acast. See acast.com/privacy for more information.